Latest Regulation News

WhiteHawk Limited reports steady Q3 revenue and advances key contracts, positioning itself to capitalise on new U.S. cybersecurity compliance rules.

Elementos Limited advances its Oropesa Tin Project in Spain and Cleveland Tin Project in Tasmania, securing a binding option to acquire 50% of a Spanish tin smelter, positioning itself as the European Union’s primary vertically integrated tin producer amid strong tin prices.

Locate Technologies has ended its Australian ATM Facility, initiated a new NZ$10 million facility in New Zealand, and proposed a share buy-back pending shareholder approval, aligning with its Bitcoin Treasury ambitions.

Besra Gold Inc has updated its Bau Gold Project resource to 2.28 million ounces and is intensifying efforts to renew a critical mining lease, signaling a strategic reset for the company.

EQT Holdings Limited reported a robust 60% increase in net profit after tax for FY25, completing a strategic transformation while navigating significant regulatory challenges. The company outlined a growth-focused strategy for FY26, emphasizing digital innovation and margin improvement.

Cobalt Blue Holdings advances its Kwinana Cobalt Refinery with a critical Works Approval and secures letters of intent covering 70% of initial production, while its Broken Hill Cobalt Project gains a three-year Major Project Status extension.

Bioxyne Limited has reported a record-breaking first quarter for FY26, with revenues soaring 210% year-on-year, driven by strong demand in cannabis products and strategic European market advances.

Medallion Metals has executed a binding agreement to acquire the Forrestania Nickel Operation from IGO, expanded its Ravensthorpe gold-copper resource to nearly 1 million ounces gold equivalent, and secured a $50 million prepayment facility with Trafigura to advance project development.

Lynas Rare Earths delivered record quarterly sales revenue of A$200.2 million in Q1 FY26, bolstered by a successful $932 million equity raise and strategic partnerships aimed at securing critical rare earth supply chains outside China.

Bioxyne Limited has reported a record quarterly revenue of A$14.1 million for Q1 FY26, driven by strong demand in Europe and Australia, alongside a strategic dual listing on the Frankfurt Stock Exchange.

Challenger Limited reported a robust 9% rise in normalised net profit after tax to $456 million for FY25, alongside an 11% dividend increase, while welcoming APRA's capital reforms that promise to boost its financial resilience and growth in retirement income products.

Little Green Pharma reported a robust September quarter with revenue exceeding $10 million, driven by growth across all product lines and strong European market performance. The company is poised to benefit from upcoming regulatory reforms and operational efficiencies.